Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000234012 | SCV000283069 | likely benign | Ataxia-telangiectasia syndrome | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000481088 | SCV000572197 | uncertain significance | not provided | 2021-03-23 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek 2016); In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing.; Published functional studies suggest no damaging effect: no effect on splicing, however, data was not available to independently review (Casadei 2019); Observed in individuals with endometrial and other cancers (Ring 2016, Casadei 2019); This variant is associated with the following publications: (PMID: 27443514, 31843900) |
Color Diagnostics, |
RCV000776130 | SCV000911075 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-22 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005396739 | SCV006058241 | uncertain significance | Familial cancer of breast; Ataxia-telangiectasia syndrome | 2020-06-23 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000234012 | SCV000789432 | uncertain significance | Ataxia-telangiectasia syndrome | 2017-01-31 | no assertion criteria provided | clinical testing | This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. |
King Laboratory, |
RCV001171475 | SCV001251390 | benign | not specified | 2019-09-01 | no assertion criteria provided | research |